# Zach Weinberg

> Zach Weinberg is a seed investor at Curie.Bio (New York) backing Software and Health Care. See 73 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Curie.Bio](https://shizune.co/investors/profile/curie-bio)
- Location: New York, United States
- Total investments: 73
- Last investment: Jun 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/zachweinberg
- X (Twitter): http://twitter.com/zachweinberg
- Website: https://x.com/zachweinberg

Zach Weinberg is a seed investor at Curie.Bio in New York focused on Software and Health Care. Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.4M–$7.6M |
| Pre-Seed | $1.5M–$2.3M |
| Series A | $3M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 22 | 30% |
| Health Care | 18 | 25% |
| Medical | 9 | 12% |
| Artificial Intelligence | 9 | 12% |
| SaaS | 8 | 11% |

117 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 38 | 52% |
| Series A | 19 | 26% |
| Pre-Seed | 4 | 5% |
| Series B | 4 | 5% |
| Funding Round | 3 | 4% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 55 | 75% |
| Israel | 1 | 1% |
| Colombia | 1 | 1% |
| United Kingdom | 1 | 1% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Crosby | Crosby is a company with programmers from Ramp, Vanta, Meta, and Google joining attorneys. | $5.8M | Seed | Jun 17, 2025 |  |
| Nourish | Nourish is a healthcare technology company that connects patients with registered dietitians through virtual nutrition counseling services covered by insurance plans. The platform allows users to find dietitians based on their health goals and attend appointments through telehealth, while also offering tools for meal tracking, goal monitoring, andnutrition guidance through its mobile application. Nourish works with registered dietitian nutritionists who provide support for conditions such as diabetes, weight management, cardiovascular health, eating disorders, and pediatric nutrition care. The company states that it partners with major insurance providers to reduce out-of-pocket costs for patients and offers ongoing nutritional care through recurring consultations. In addition to patient services, Nourish publishes educational resources and uses data-driven approaches to support personalized nutrition planning and long-term health management. | $8M | Seed | Feb 01, 2023 |  |
| Scoop | Scoop is a creator of multi-platform tools that enable businesses and workers to take advantage of flexible work arrangements.The company's platform provides the tools and information required to reduce operational costs while giving workers the opportunity to work from any location, making it simple for businesses to run both an in-officeand remote environment.Scoop was established in January 2015 by Rob Sadow and Jonathan Sadow in San Francisco, California. | $8M | Seed | Nov 17, 2022 |  |
| Overwatch Research | Overwatch Research provides an all-in-one experimental tracking software for Vivo research. Overwatch Research affords to Save time, reduce error and increase collaboration in the lab. | $3.5M | Seed | Oct 19, 2021 |  |
| Oshi Health | Oshi Health is a virtual-first gastroenterology (GI) clinic that diagnoses, treats and remotely monitors digestive (GI) conditions. Patients work with Oshi Health's integrated care team of gastroenterologists and GI-specialized nurse practitioners, registered dietitians, behavioral psychologists and health coaches to determine the root causesof their symptoms and use a personalized care plan that includes medication, dietary interventions and stress/anxiety reduction to get symptoms under control. This yields improved health outcomes, quality of life, satisfaction with care and workplace productivity while reducing overall healthcare cost. | $23M | Series A | Oct 12, 2021 |  |
| Iterative Scopes | Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space. The company was founded in 2017 and is based in Cambridge, Massachusetts. | $30M | Series A | Aug 03, 2021 |  |
| Iterative Health | Iterative Health is a healthcare technology and services company that focuses on accelerating clinical research to improve patient outcomes through innovative approaches. The company transforms gastrointestinal (GI) care by utilizing AI-driven clinical trials and diagnostics, significantly enhancing access to vital treatments. | $30M | Series A | Aug 03, 2021 |  |
| Connie Health | Connie Health empowers older Americans to make confident, worry-free healthcare decisions. | $13M | Series A | Jul 28, 2021 |  |
| Nym | Nym transforms revenue cycle management by fully automating the medical coding process. Our engine deciphers clinical language in patient charts and accurately assigns medical charge codes in seconds and with zero human intervention. By automating medical coding with Nym, healthcare providers can improve coding quality while significantlyreducing the time and cost associated with medical coding. This ultimately ensures clinical and administrative teams can spend more time focused on patient care. | $25M |  | Jul 27, 2021 |  |
| Nym | Nym transforms revenue cycle management by fully automating the medical coding process. Our engine deciphers clinical language in patient charts and accurately assigns medical charge codes in seconds and with zero human intervention. By automating medical coding with Nym, healthcare providers can improve coding quality while significantlyreducing the time and cost associated with medical coding. This ultimately ensures clinical and administrative teams can spend more time focused on patient care. | $25M | Series B | Jul 27, 2021 |  |

10 of 73 investments shown.

## Co-investors
- [Operator Partners](https://shizune.co/investors/profile/operator-partners) — VC Fund, 11 deals together
- [Great Oaks Venture Capital](https://shizune.co/investors/profile/great-oaks-venture-capital) — VC Fund, 7 deals together
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 6 deals together
- [BoxGroup](https://shizune.co/investors/profile/boxgroup) — VC Fund, 6 deals together
- [Founder Collective](https://shizune.co/investors/profile/founder-collective) — VC Fund, 6 deals together
- [Arkitekt Ventures](https://shizune.co/investors/profile/arkitekt-ventures) — VC Fund, 5 deals together

## About Curie.Bio

VC Fund

Curie.Bio is a founder-focused seed-stage venture capital firm.

4 contacts available at Curie.Bio.

| Name | Title | Profile |
| --- | --- | --- |
| Alexis Borisy | Co-Founder & Chairman | https://shizune.co/investors/profile/alexis-borisy |
| Zach Weinberg | Co-Founder and CEO | https://shizune.co/investors/profile/zach-weinberg |
| Ben Auspitz | Managing Partner, Breakout Fund | https://shizune.co/investors/profile/ben-auspitz |
| Christoph Lengauer | Co-Founder and CSO | https://shizune.co/investors/profile/christoph-lengauer |

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Soma Capital](https://shizune.co/investors/profile/soma-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [All Angel Investors in United States](https://shizune.co/investors/angel-investors-united-states)
- [Software Angel Investors in United States](https://shizune.co/investors/software-angel-investors-united-states)
- [Health Care Angel Investors](https://shizune.co/investors/health-care-angel-investors)
- [Health Care Angel Investors in United States](https://shizune.co/investors/health-care-angel-investors-united-states)
- [FinTech Angel Investors in United States](https://shizune.co/investors/fintech-angel-investors-united-states)
- [Financial Services Angel Investors in United States](https://shizune.co/investors/financial-services-angel-investors-united-states)

## FAQ

### What does Zach Weinberg invest in?

Zach Weinberg invests primarily in Software, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 73 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Zach Weinberg's check size?

Zach Weinberg typically joins rounds of $1.4M–$7.6M at Seed, $1.5M–$2.3M at Pre-Seed and $3M–$30M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Zach Weinberg participates in.

### When did Zach Weinberg last invest?

The most recent investment recorded for Zach Weinberg closed in Jun 2025. Shizune tracks 73 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co